SEATTLE (Reuters) - For Joe Cohen, a GlaxoSmithKline research scientist who has spent 24 years trying to create the world's first malaria vaccine, Tuesday, Oct. 18, 2011 goes down as a fabulous day.
"There were many ups and downs, and moments over the years when we thought 'Can we do it? Should we continue? Or is it really just too tough?," he told Reuters, as data showing the success of his RTS,S vaccine were unveiled at an international conference on malaria.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!